Resource Logo
CDC HIV/AIDS/Viral Hepatitis/STD/TB Prevention News Update

NEW YORK: ACT UP Applauds NYC DOH's Use of PrEP to Reduce HIV


Edge on the Net (01.27.2014)

Edge on the Net reported that the AIDS Coalition to Unleash Power/New York (ACT UP/NY) praised New York State’s Department of Health (NYS DOH) AIDS Institute for releasing pre-exposure prophylaxis (PrEP) guidelines for preventing HIV transmission in at-risk individuals. PrEP means taking the antiretroviral Truvada prior to exposure to prevent HIV. Terry Roethlein, an ACT UP member, attributed the release of the PrEP guidelines on January 14, 2014, to ACT UP pressure and communication with NYS DOH AIDS Institute. The US Food and Drug Administration approved Truvada’s use of PrEP in July 2012. Since that time, 5,000 individuals in New York have received HIV diagnoses, according to CDC data. ACT UP is demanding that New York State take specific measures to reduce state infection rates. Act UP recommended PrEP-related continuing education courses for healthcare providers and public education campaigns for healthcare providers and the public, particularly for at-risk communities such as men who have sex with men (MSM), young MSM of color, and transgender women. Suggestions also include funding for healthcare organizations to make PrEP available to at-risk poor and uninsured individuals as well as to provide material on available resources. ACT UP/NY also would like certain commitments from the governor and state that would help reduce transmission and lower viral loads, including use of newer methods such as PrEP and post-exposure prophylaxis.


Copyright © 2014 -CDC Prevention News Update, Publisher. All rights reserved to Information, Inc., Bethesda, MD. The CDC National Center for HIV, STD and TB Prevention provides the following information as a public service only. Providing synopses of key scientific articles and lay media reports on HIV/AIDS, other sexually transmitted diseases and tuberculosis does not constitute CDC endorsement. This daily update also includes information from CDC and other government agencies, such as background on Morbidity and Mortality Weekly Report (MMWR) articles, fact sheets, press releases and announcements. Reproduction of this text is encouraged; however, copies may not be sold, and the CDC HIV/STD/TB Prevention News Update should be cited as the source of the information. Contact the sources of the articles abstracted below for full texts of the articles.

Information in this article was accurate in January 29, 2014. The state of the art may have changed since the publication date. This material is designed to support, not replace, the relationship that exists between you and your doctor. Always discuss treatment options with a doctor who specializes in treating HIV.